Yes — a throat swab can detect influenza, but nasal or nasopharyngeal swabs are generally more sensitive. Both rapid antigen tests and PCR can be performed on throat samples; PCR (molecular) testing is the most accurate. Testing early after symptom onset improves detection. If flu is strongly suspected despite a negative throat swab, clinicians may repeat testing or collect a nasopharyngeal swab for greater sensitivity.

Yes—H1N1 influenza commonly causes a sore throat, often along with fever, cough, runny or stuffy nose, body aches, headache and fatigue. The sore throat is typically mild to moderate and improves within a few days. Seek medical care if throat pain is severe or accompanied by difficulty breathing, persistent high fever, confusion, or dehydration. Early antiviral treatment can reduce complications.

The RT‑PCR test for H1N1 is a real‑time reverse transcription polymerase chain reaction that detects H1N1 influenza viral RNA in respiratory samples (nasopharyngeal/throat swabs, sputum). The assay converts viral RNA to DNA, amplifies specific genes, and provides highly sensitive and specific confirmation of infection within hours. It distinguishes influenza types/subtypes and guides treatment and public‑health responses.

Depending on the test: rapid antigen tests return results in about 10 to 30 minutes but are less sensitive; molecular tests (RT‑PCR) usually take a few hours to a day in the lab, or 1 to 2 days if samples are sent to a reference laboratory. Viral culture, rarely used for routine diagnosis, can take several days to a week.

Throat swabs can detect many respiratory viruses, typically by PCR or antigen testing: SARS‑CoV‑2, influenza A and B, respiratory syncytial virus (RSV), adenoviruses, parainfluenza viruses, rhinoviruses (common cold), human metapneumovirus, and enteroviruses. Some less common viral pathogens may be identified (e.g., herpes simplex, Epstein‑Barr) when pharyngeal shedding occurs. Test choice and sampling site affect sensitivity.

Testing for H1N1 uses respiratory samples (nasopharyngeal or nasal/throat swabs). Rapid antigen tests give quick results but have lower sensitivity. Molecular tests (RT‑PCR) are preferred—more accurate and detect viral RNA—often done on nasopharyngeal swabs and considered the diagnostic standard. Viral culture is rarely used clinically. Clinicians prioritize testing for hospitalized, high‑risk, pregnant, or severe cases, preferably early in illness.